CollPlant receives green light to advance collagen-based bioink

CollPlant (Ness Ziona, Israel) has received approval from the Israel Innovation Authority to research and develop a collagen-based bioink for printing tissues and organs. CollPlant (Ness Ziona, Israel), a regenerative medicine company, has announced it has received grant approval from the Israel Innovation Authority (IIA) to finance the research and development of its proprietary plant-based recombinant human collagen (rhCollagen) – a technology utilized for tissue repair products. The grant will allow CollPlant to advance current research and to begin to develop a strategy for the use of rhCollagen as a component of bioink for the 3D printing of tissues, and...